MODD

S-3 - Modular Medical, Inc. (0001074871) (Filer)

8-K - Modular Medical, Inc. (0001074871) (Filer)

424B5 - Modular Medical, Inc. (0001074871) (Filer)

SAN DIEGO, CA / ACCESS Newswire / April 19, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced the pricing of a registered direct offering (the "Offering") consisting of 750,000 shares of the Company's common stock at an offering price of $4.50 per share. The gross proceeds to the Company from the Offering are estimated to be approximately $3.4 million before deducting placement agent fees and other offering expenses. The Offering is expected to close on or about April 21, 2026, subject to the satisfaction of customary closing conditions.Maxim Group LLC is acting as the sole placement agen

8-K - Modular Medical, Inc. (0001074871) (Filer)

SAN DIEGO, CA / ACCESS Newswire / April 16, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced that it has received a letter from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq Capital Market's minimum bid price continued listing requirement. The letter noted that, as of April 14, 2026, the Company evidenced a closing bid price of its common stock in excess of the $1.00 minimum requirement for the last 10 consecutive trading days. Accordingly, the Company has regained compliance with Nasdaq Marketplace Rule 5550(a)(2) and Nasdaq

4 - Modular Medical, Inc. (0001074871) (Issuer)

First Removable 2-Part Design Targets $3 Billion "Almost-Pumper" Market with Expected Q2 2026 initial deployment.Key Milestones & Investment Highlights:FDA 510(k) Clearance Achieved: Pivot™ pump now cleared for commercial sale in the U.S. - major de-risking event unlocking revenue path.First-in-Class Removable Tubeless Patch Pump: 3 mL detachable reservoir; no battery recharging required; removable for showering, sports or discretion; quick bolus button without a separate controller.Targets Massive Underserved Market: ~70% of insulin-dependent adults remain on multiple daily injections (MDI) due to complexity, cumbersomeness and cost - Pivot addresses the "3 Cs" for "almost-pumpers" with its

4 - Modular Medical, Inc. (0001074871) (Issuer)

4 - Modular Medical, Inc. (0001074871) (Issuer)

4 - Modular Medical, Inc. (0001074871) (Issuer)

4 - Modular Medical, Inc. (0001074871) (Issuer)

4 - Modular Medical, Inc. (0001074871) (Issuer)

4 - Modular Medical, Inc. (0001074871) (Issuer)

8-K - Modular Medical, Inc. (0001074871) (Filer)

SAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), an innovative insulin delivery technology company, today announced that it will effect a 1-for-30 reverse stock split of its outstanding common stock. The reverse stock split will become effective at 5:30am ET on March 31, 2026. The common stock is expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market ("Nasdaq") under the same symbol "MODD" when the market opens on March 31, 2026, with the new CUSIP number 60785L306.The reverse stock split was approved by the Company's shareholders at the Company's fiscal 2026 Annual Meeting, held on January

S-8 - Modular Medical, Inc. (0001074871) (Filer)

8-K - Modular Medical, Inc. (0001074871) (Filer)

8-K - Modular Medical, Inc. (0001074871) (Filer)

424B4 - Modular Medical, Inc. (0001074871) (Filer)

EFFECT - Modular Medical, Inc. (0001074871) (Filer)

SAN DIEGO, CA / ACCESS Newswire / March 3, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced the pricing of a public offering with new and existing investors of 68,098,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 68,098,000 shares of its common stock at a combined public offering price of $0.1762 per share (or pre-funded warrant) and accompanying warrant. The warrants will have an exercise pric

S-1 - Modular Medical, Inc. (0001074871) (Filer)

8-K - Modular Medical, Inc. (0001074871) (Filer)

10-Q - Modular Medical, Inc. (0001074871) (Filer)